Showing results (321-330 of 369) with videos related to
Sort By:
Pageof 37
Annals of Hepatology|December 24, 2014
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease durationRosa Zampino, Maria A Pisaturo, Grazia Cirillo, et al.World Journal of Gastroenterology|March 16, 2017
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosisLuca Rinaldi, Fabio Nascimbeni, Mauro Giordano, et al.European Journal of Clinical Investigation|October 10, 2025
Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triadAlfredo Caturano, Enes Erul, Roberto Nilo, et al.BMC Medical Genetics|February 2, 2017
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variantsGabriella Esposito, Francesco Testa, Miriam Zacchia, et al.Cardiovascular Diabetology|November 7, 2022
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trialFerdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, et al.Digestive Diseases and Sciences|April 3, 2019
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life ExperienceLuca Rinaldi, Maria Guarino, Alessandro Perrella, et al.Journal of Clinical Medicine|May 14, 2022
Prediction of SARS-CoV-2-Related Lung Inflammation Spreading by V:ERITAS (Vanvitelli Early Recognition of Inflamed Thoracic Areas Spreading)Ciro Romano, Domenico Cozzolino, Giovanna Cuomo, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 2, 2020
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND studyPia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, et al.Antioxidants (Basel, Switzerland)|January 25, 2025
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle ModificationsAlfredo Caturano, Maria Rocco, Giuseppina Tagliaferri, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital FrontiersErica Vetrano, Alfredo Caturano, Davide Nilo, et al.Pageof 37